• AIFA 2022 research grants announced
    The Allergy and Immunology Foundation of Australasia (AIFA) research grants for 2022 were announced at the  ASCIA 2022 Conference AIFA Research Symposium, which also featured presentations by 2020 AIFA grant recipients. To read more go to
  • ASCIA AGM 2022
    The ASCIA Annual General Meeting (AGM) 2022 was held on Friday 2nd September, and Minutes are available here We welcome A/Prof Theresa Cole as the new ASCIA President and thank Prof Michaela Lucas for her excellent leadership as the...
  • ASCIA 2022 Conference Report
    The ASCIA 2022 Conference was a highly successful hybrid event which was held from Tuesday 30th August to Friday 2nd September, with in-person participation in Melbourne. The conference attracted more than 600 registered delegates, with around 60 per cent of delegates...
  • Anapen® now approved for 3 seconds
    The time for Anapen® adrenaline (epinephrine) autoinjectors to be held in place has now been approved for 3 seconds (reduced from 10 seconds) by the Therapeutic Goods Administration (TGA). Whilst the time has reduced from 10 to 3 seconds, Anapen® devices have not changed...
  • Launch of National Allergy Council and National Allergy Centre of Excellence
    In a major step towards addressing Australia’s allergy epidemic, the Hon. Ged Kearney MP, Assistant Minister for Health and Aged Care, alongside allergy experts, has launched two world-first allergy organisations at a media event on Wednesday 31st August 2022 in Melbourne,...
  • Improved access to ASCIA website information
    The ASCIA team works with ASCIA member committees and working parties to review, update and develop world leading, accessible, consistent and evidence based online resources, education and training, to support ASCIA members, other health professionals, patients, carers and the...
  • New Food Allergy Course for Residential Care
    A new food allergy training course for staff working with vulnerable people in a variety of residential care settings has been developed as part of the National Allergy Strategy. The course is intended for staff working in aged care and other residential care, transitional...
  • New ASCIA Radiocontrast Media Position Statement
    The new ASCIA Radiocontrast Media Position Statement for health professionals is available at Radiocontrast media (RCM) are a group of medical drugs used to improve the visibility of internal organs and...
ASCIA Member Login

Site last updated:  9 Sep 2022

ASCIA Update

Information for the community about allergic diseases, immunodeficiencies and other immune diseases.
See latest edition here...

Join our mailing list here...

AIFA: Donate Now
AIFA: Donate Now
National Allergy Strategy
National Allergy Council

ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links


ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Information Partner